Next Century Growth Investors LLC Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Next Century Growth Investors LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 72.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,890 shares of the medical equipment provider's stock after acquiring an additional 2,893 shares during the period. Next Century Growth Investors LLC's holdings in Intuitive Surgical were worth $3,596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Atala Financial Inc purchased a new stake in Intuitive Surgical in the fourth quarter worth about $25,000. Hurley Capital LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $28,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, Summit Securities Group LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 0.4 %

Shares of NASDAQ ISRG traded down $1.86 during trading on Tuesday, reaching $488.27. 1,732,465 shares of the company traded hands, compared to its average volume of 1,600,345. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock has a market cap of $173.91 billion, a P/E ratio of 76.17, a PEG ratio of 5.85 and a beta of 1.55. The firm's fifty day simple moving average is $530.71 and its 200 day simple moving average is $532.76.

Remove Ads

Analyst Ratings Changes

ISRG has been the topic of a number of analyst reports. Evercore ISI lifted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Piper Sandler restated an "overweight" rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Finally, Bernstein Bank upped their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $611.86.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.